kneat.com (KSI) Aperçu de l'action
kneat.com, inc. et ses filiales conçoivent, développent et fournissent des logiciels pour la gestion des données et des documents dans des environnements réglementés en Amérique du Nord, en Europe et dans la région Asie-Pacifique. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 2/6 |
| Croissance future | 1/6 |
| Performances passées | 0/6 |
| Santé financière | 4/6 |
| Dividendes | 0/6 |
KSI Community Fair Values
Create NarrativeSee what 15 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
kneat.com, inc. Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | CA$6.48 |
| Plus haut sur 52 semaines | CA$6.50 |
| Plus bas sur 52 semaines | CA$3.23 |
| Bêta | 1.33 |
| Variation sur 1 mois | 0.15% |
| Variation sur 3 mois | 37.00% |
| Variation sur 1 an | 8.18% |
| Variation sur 3 ans | 93.43% |
| Variation sur 5 ans | 94.01% |
| Évolution depuis l'introduction en bourse | 1,751.43% |
Nouvelles et mises à jour récentes
KSI: Pending Thoma Bravo Buyout Will Frame Fairly Valued Upside And Risks
The updated analyst fair value estimate for kneat.com edges up to CA$6.35 from CA$6.10, reflecting price targets that have converged around the CA$6.50 cash offer as analysts adjust their views following the proposed acquisition by an affiliate of Thoma Bravo. Analyst Commentary Recent street research on kneat.com has clustered around the proposed C$6.50 cash offer, with analysts updating ratings and targets to reflect the pending acquisition and a narrower range of potential outcomes for the stock.KSI: Life Sciences Validation Adoption And Committee Review Will Support Future Upside
Analyst price targets for kneat.com have shifted higher into a CA$5.75 to CA$6.25 range, reflecting updated views on fair value at CA$6.10, a revised future P/E of about 51x, improved profit margin assumptions, and recent Street research updates from multiple firms. Analyst Commentary Bullish Takeaways Bullish analysts are aligning around a CA$5.75 to CA$6.25 price target range, which signals confidence in the updated fair value assumption of about CA$6.10 relative to the current fundamentals.Recent updates
KSI: Pending Thoma Bravo Buyout Will Frame Fairly Valued Upside And Risks
The updated analyst fair value estimate for kneat.com edges up to CA$6.35 from CA$6.10, reflecting price targets that have converged around the CA$6.50 cash offer as analysts adjust their views following the proposed acquisition by an affiliate of Thoma Bravo. Analyst Commentary Recent street research on kneat.com has clustered around the proposed C$6.50 cash offer, with analysts updating ratings and targets to reflect the pending acquisition and a narrower range of potential outcomes for the stock.KSI: Life Sciences Validation Adoption And Committee Review Will Support Future Upside
Analyst price targets for kneat.com have shifted higher into a CA$5.75 to CA$6.25 range, reflecting updated views on fair value at CA$6.10, a revised future P/E of about 51x, improved profit margin assumptions, and recent Street research updates from multiple firms. Analyst Commentary Bullish Takeaways Bullish analysts are aligning around a CA$5.75 to CA$6.25 price target range, which signals confidence in the updated fair value assumption of about CA$6.10 relative to the current fundamentals.KSI: Life Sciences Validation Adoption And Special Committee Review Will Support Future Upside
Analysts have increased the fair value estimate for kneat.com from CA$5.70 to CA$5.90, aligning it with recent Street price target adjustments in the CA$5.50 to CA$6.25 range and reflecting views on the company's growth profile, margins and P/E expectations. Analyst Commentary Recent Street research around kneat.com has focused on recalibrating price targets while keeping positive ratings in place.KSI: Pharma Packaging Agreements And Data Integrity Adoption Will Support Future Upside
Narrative Update Analysts have trimmed their blended price target on kneat.com by CA$1.00 to CA$5.50, reflecting recent target cuts from CA$6.50, while still citing supportive views on the business outlook. Analyst Commentary Recent research suggests that while price targets on kneat.com have been reset to CA$5.50, the general tone from covering firms still leans supportive, with ratings such as Buy and Outperformer maintained alongside a fresh, constructive initiation.KSI: Global Pharma Agreements And Data Integrity Adoption Will Support Future Margin Expansion
Analysts have trimmed their average price target on kneat.com to CA$5.50 from CA$6.50, citing refreshed assumptions around discount rates, long term growth expectations and valuation multiples, while generally maintaining positive ratings on the shares. Analyst Commentary Recent research on kneat.com points to a reset in expectations, with price targets grouped around CA$5.50 and ratings that remain generally constructive on the company’s execution and growth potential.KSI: Data Integrity Adoption And New Pharma Wins Will Support Future Margin Expansion
The analyst price target for kneat.com has been trimmed to CA$5.50 from CA$6.50. Analysts are factoring in an updated fair value of CA$5.70, a modestly higher discount rate, and adjusted revenue growth and profit margin assumptions, while still citing generally positive research commentary on the shares.KSI: Data Integrity Adoption Will Support Future Margin Expansion Despite Reset Expectations
Analysts have reduced their fair value estimate for kneat.com to CA$5.75 from CA$6.67. This change reflects recent cuts to Street price targets to around CA$5.50 and more cautious assumptions on growth, margins, and future P/E.KSI: Data Integrity Adoption Will Support Future Margin Expansion Potential
Analysts have maintained their CA$6.67 price target on kneat.com, citing supportive TD Securities research. The research highlights the company’s growth profile and long-term margin potential, as reflected in modest adjustments to the discount rate, revenue growth, and future P/E assumptions.KSI: Global Validation Wins And Bullish Coverage Will Support Future Upside
Analysts have trimmed their price expectations for kneat.com, with recent targets moving from C$7.50 to C$5.50 and from C$8.50 to C$7.50. This reflects updated views on fair value, profitability assumptions and future P/E levels, while a new bullish initiation from TD Securities highlights ongoing interest in the name.KSI: Global Validation Agreements Will Support Future Upside Despite Lowered Street Expectations
Narrative update on kneat.com The analyst price target for kneat.com has been revised lower to C$5.50 to C$7.50, down from C$7.50 to C$8.50, as analysts adjust their views while maintaining positive ratings on the shares. Analyst Commentary Recent research reflects a mixed but generally constructive stance on kneat.com, with both supporting and cautionary points tied to the revised price targets of C$5.50 and C$7.50 and the maintained positive ratings.KSI: Global Validation Agreements Will Support Future Upside Despite Recent Estimate Revisions
Analysts nudged their fair value estimate for kneat.com to C$6.80 from C$6.60. Recent Street price target updates to C$5.50 and C$7.50 helped frame the new outlook on discount rates, revenue growth, profit margins and future P/E assumptions.KSI: Expanding Global Validation Agreements Will Drive Future Outperformance
We lower our Kneat.com price target to C$5.50 from C$7.50, reflecting analysts' reduced near term expectations for valuation multiples, despite largely unchanged long term growth and margin assumptions. Analyst Commentary Recent Street research reflects a more tempered near term outlook for Kneat.com, with price targets revised lower but positive ratings maintained, signaling continued confidence in the company’s underlying growth trajectory.KSI: Expansion Of Global Customer Agreements Will Drive Outperformance Ahead
Analysts have reduced their average price target for kneat.com from $6.80 to $6.60. This change is attributed to recent downward revisions to growth and profit forecasts.Market Cool On kneat.com, inc.'s (TSE:KSI) Revenues Pushing Shares 26% Lower
The kneat.com, inc. ( TSE:KSI ) share price has fared very poorly over the last month, falling by a substantial 26...KSI: Momentum In Securing New Customers Will Drive Performance Ahead
Analysts have lowered their price targets for kneat.com. Target estimates have decreased from C$8.50 and C$7.50 previously to updated levels of C$7.50 and C$5.50 respectively, citing slower expected revenue growth and a slightly higher discount rate as key factors in their revised outlook.
Life Sciences Wins And Expanded Sales Will Open Future Markets
Strategic wins and expansions in multiple sectors, alongside enhanced AI tools, are expected to boost revenue and improve net margins.kneat.com, inc. (TSE:KSI) Just Reported And Analysts Have Been Lifting Their Price Targets
It's been a pretty great week for kneat.com, inc. ( TSE:KSI ) shareholders, with its shares surging 15% to CA$6.88 in...A Look At The Intrinsic Value Of kneat.com, inc. (TSE:KSI)
Key Insights The projected fair value for kneat.com is CA$5.19 based on 2 Stage Free Cash Flow to Equity Current share...Investors Still Waiting For A Pull Back In kneat.com, inc. (TSE:KSI)
With a price-to-sales (or "P/S") ratio of 10.1x kneat.com, inc. ( TSE:KSI ) may be sending very bearish signals at the...Is kneat.com (TSE:KSI) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Here's Why We're Not Too Worried About kneat.com's (TSE:KSI) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, although...Fewer Investors Than Expected Jumping On kneat.com, inc. (TSE:KSI)
There wouldn't be many who think kneat.com, inc.'s ( TSE:KSI ) price-to-sales (or "P/S") ratio of 8.7x is worth a...Rendement pour les actionnaires
| KSI | CA Healthcare Services | CA Marché | |
|---|---|---|---|
| 7D | 0.2% | -1.0% | 0.7% |
| 1Y | 8.2% | -16.7% | 30.5% |
Rendement vs Industrie: KSI a dépassé le secteur Canadian Healthcare Services qui a rapporté -16.7 % au cours de l'année écoulée.
Rendement vs marché: KSI a sous-performé le marché Canadian qui a rapporté 30.5 % au cours de l'année écoulée.
Volatilité des prix
| KSI volatility | |
|---|---|
| KSI Average Weekly Movement | 6.5% |
| Healthcare Services Industry Average Movement | 8.9% |
| Market Average Movement | 9.5% |
| 10% most volatile stocks in CA Market | 16.3% |
| 10% least volatile stocks in CA Market | 3.7% |
Cours de l'action stable: KSI n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché Canadian.
Volatilité au fil du temps: La volatilité hebdomadaire de KSI ( 6% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 2007 | 343 | Eddie Ryan | kneat.com |
kneat.com, inc. et ses filiales conçoivent, développent et fournissent des logiciels pour la gestion des données et des documents dans des environnements réglementés en Amérique du Nord, en Europe et dans la région Asie-Pacifique. La société propose la plateforme Kneat Gx, une application configurable prête à l'emploi axée sur la gestion du cycle de vie de la validation et les tests pour les industries de fabrication de biotechnologies, de produits pharmaceutiques et d'appareils médicaux. Cette plateforme est utilisée dans diverses applications, notamment la gestion des documents, la validation des instruments d'analyse, la validation des méthodes, la mise en service et la qualification, la gestion des dessins, la validation des services publics et des installations, la validation de la chaîne du froid, la gestion des carnets de bord électroniques, la validation des processus, la validation des systèmes informatiques et la validation du nettoyage.
kneat.com, inc. Résumé des fondamentaux
| KSI statistiques fondamentales | |
|---|---|
| Capitalisation boursière | CA$626.02m |
| Bénéfices(TTM) | -CA$8.44m |
| Recettes(TTM) | CA$66.52m |
Le site KSI est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| KSI compte de résultat (TTM) | |
|---|---|
| Recettes | CA$66.52m |
| Coût des recettes | CA$15.54m |
| Marge brute | CA$50.97m |
| Autres dépenses | CA$59.41m |
| Les revenus | -CA$8.44m |
Derniers bénéfices déclarés
Mar 31, 2026
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | -0.087 |
| Marge brute | 76.63% |
| Marge bénéficiaire nette | -12.69% |
| Ratio dettes/capitaux propres | 31.6% |
Quelles ont été les performances à long terme de KSI?
Voir les performances historiques et les comparaisonsAnalyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/08/04 06:43 |
| Cours de l'action en fin de journée | 2026/08/04 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
kneat.com, inc. est couverte par 9 analystes. 5 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Gavin Fairweather | ATB Cormark |
| Douglas Taylor | Canaccord Genuity |
| Stephanie Price | CIBC Capital Markets |